Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of ATP5G3 mRNA | affects expression | 21346803
|
C099555 |
CD 437 |
CD 437 results in decreased expression of ATP5G3 mRNA | decreases expression | 12958071
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of ATP5G3 mRNA | decreases expression | 20106945
|
D019259 |
Lamivudine |
[Zidovudine co-treated with Lamivudine] results in decreased expression of ATP5G3 mRNA | affects cotreatment|decreases expression | 18313992
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of ATP5G3 mRNA | affects cotreatment|increases expression | 17183730
|
C059514 |
resveratrol |
resveratrol results in increased expression of ATP5G3 mRNA | increases expression | 17112576
|
D012402 |
Rotenone |
Rotenone results in increased expression of ATP5G3 mRNA | increases expression | 18191903
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ATP5G3 mRNA | increases expression | 20399798
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of ATP5G3 mRNA | affects cotreatment|increases expression | 17183730
|
D015215 |
Zidovudine |
Zidovudine results in increased expression of ATP5G3 mRNA | increases expression | 16894629
|
D015215 |
Zidovudine |
[Zidovudine co-treated with Lamivudine] results in decreased expression of ATP5G3 mRNA | affects cotreatment|decreases expression | 18313992
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.11 | 14514962 11752688 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
9.11 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.10 | 19490988 |
MESH:D000163 |
Acquired Immunodeficiency Syndrome |
|
Zidovudine |
5.04 | 9612607 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
4.02 | 16538975 |
MESH:D000236 |
Adenoma |
|
resveratrol |
3.41 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.61 | 16835633 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.60 | 16183991 16162502 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.50 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.11 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.71 | 17497229 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
3.60 | 17115116 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.37 | 16873680 17967414 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 18396377 18985861 17157402 17507914 17688650 18558336 19232924 15238991 19460635 18316065 18775368 18940202 18177632 20603192 16609825 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.15 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.21 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.06 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.37 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.37 | 8888407 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.52 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.12 | 17651959 16393696 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.12 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.93 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.23 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
3.23 | 16227395 19321006 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.83 | 16675471 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
2.75 | 16227395 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.45 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.59 | 15458977 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
6.96 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.96 | 12371664 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.76 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.31 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.04 | 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.16 | 12621046 16354765 15340226 8697196 15668235 |
MESH:D003092 |
Colitis |
|
resveratrol |
4.34 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
2.48 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.22 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.85 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.52 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.52 | 8888407 16575769 17688650 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.23 | 18551238 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.91 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.70 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
4.11 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.46 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.46 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
6.46 | 19641884 1733752 |
MESH:D004362 |
Drug Toxicity |
|
Lamivudine |
14.62 | 15040536 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
14.62 | 11462148 |
MESH:D004362 |
Drug Toxicity |
|
Zidovudine |
14.62 | 15040536 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.23 | 1851702 |
MESH:D004487 |
Edema |
|
resveratrol |
7.44 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.44 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.17 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
4.22 | 17872969 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.18 | 10568697 9294722 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
5.06 | 17923197 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.37 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.18 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.01 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.74 | 6426943 7562514 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.51 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.30 | 3659116 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.14 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
14.25 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
14.25 | 19224547 14986274 |
MESH:D005234 |
Fatty Liver |
|
Zidovudine |
14.25 | 18299183 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.67 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.15 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.33 | 18558336 8888407 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.21 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.21 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.46 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.86 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.41 | 11294989 10048152 |
MESH:D006402 |
Hematologic Diseases |
|
Zidovudine |
4.90 | 12579204 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.66 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.51 | 11000095 |
MESH:D006509 |
Hepatitis B |
|
Lamivudine |
5.27 | 17703166 |
MESH:D019694 |
Hepatitis B, Chronic |
|
Lamivudine |
5.27 | 16476009 15631357 12044531 15309715 15274664 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.11 | 12621046 15340226 16120746 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.42 | 16876885 |
MESH:D015658 |
HIV Infections |
|
Lamivudine |
7.33 | 17530837 11141242 20032539 9296927 |
MESH:D015658 |
HIV Infections |
|
Zidovudine |
7.33 | 11141242 20032539 17358032 11698656 11363243 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.10 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.31 | 15340226 8697196 18606429 16959395 16354765 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
4.18 | 17188708 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
4.21 | 16873680 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.14 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.14 | 18670907 18850075 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.84 | 16612254 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.46 | 17488730 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.86 | 17600658 |
MESH:D007249 |
Inflammation |
|
resveratrol |
5.34 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.34 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.81 | 16624496 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.51 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.71 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.43 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
13.33 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
13.33 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Zidovudine |
13.33 | 12579204 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Zidovudine |
4.58 | 20370541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.17 | 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.68 | 16087638 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
7.78 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
7.78 | 20405173 19812893 19321006 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.78 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
6.07 | 6135515 2876786 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.07 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.53 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.56 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Zidovudine |
2.56 | 18800350 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.48 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
4.01 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.48 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
3.21 | 8985016 11606380 |
MESH:D008545 |
Melanoma |
|
resveratrol |
2.39 | 17992120 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.55 | 17112576 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.05 | 16801185 |
MESH:D048629 |
Micronuclei, Chromosome-Defective |
|
Zidovudine |
6.10 | 17358032 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.31 | 18803445 18765137 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.58 | 16490592 17935668 17049120 14749477 17164350 16267019 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
5.11 | 17962980 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.20 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.24 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
3.09 | 16317513 16525036 16456233 17188708 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
9.47 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
9.47 | 12213967 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
5.00 | 17322642 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.10 | 7678174 18551238 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
4.21 | 8985016 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.71 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.44 | 18481113 19348381 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
4.01 | 18619942 15790535 17356569 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.41 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.23 | 16359493 8888407 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.95 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.58 | 17929310 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.59 | 16049721 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.44 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
CD 437 |
3.36 | 17474084 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
3.03 | 18619942 15451049 16412576 19232380 18191903 11445065 16140633 11535288 19114014 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
4.24 | 15574749 15795934 15927086 18197244 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.51 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.76 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.37 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
17.73 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
17.73 | 11399792 11896295 11222880 11118676 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
17.73 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
3.61 | 16731767 17804756 17718901 17636462 17675339 15767336 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.81 | 11422049 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.28 | 16882103 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.85 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
3.35 | 16314181 17058453 15827377 16317513 17520802 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.04 | 18990726 |
MESH:D012206 |
Rhabdomyolysis |
|
Lamivudine |
5.77 | 9296927 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.36 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.32 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
6.32 | 15475178 16876388 11738929 14763951 17978042 1511512 11044598 3137016 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
5.96 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.96 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.91 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.81 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Zidovudine |
2.48 | 17696246 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.64 | 16321402 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.17 | 12697716 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
4.37 | 16227395 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.50 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.76 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.61 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
CD 437 |
5.61 | 16720286 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.86 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.56 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
4.26 | 17473185 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
4.33 | 17044934 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.25 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Zidovudine |
4.97 | 12579204 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.86 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.52 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.51 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.71 | 17120751 |